A PHASE-III RANDOMIZED PLACEBO-CONTROLED STUDY IN 315 PEDIATRIC AND ADULT AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH LENOGRASTIM-5 UG KG/DAY (GLYCOSYLATED RHU-G-CSF)/
C. Gisselbrecht et al., A PHASE-III RANDOMIZED PLACEBO-CONTROLED STUDY IN 315 PEDIATRIC AND ADULT AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION WITH LENOGRASTIM-5 UG KG/DAY (GLYCOSYLATED RHU-G-CSF)/, Blood, 82(10), 1993, pp. 10000455-10000455